Lavaca Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-24,100
Closed -$2.59M – 171
2023
Q1
$2.59M Hold
24,100
– – 0.54% 34
2022
Q4
$2.44M Hold
24,100
– – 0.76% 32
2022
Q3
$2.08M Hold
24,100
– – 0.75% 30
2022
Q2
$2.2M Buy
+24,100
New +$2.14M 0.33% 29

Other funds holding MRK

Lavaca Capital's MRK Position: Q3 2026 in Review

Lavaca Capital increased its Merck (MRK) stake by 0.43% in Q3 2026, buying an estimated $39.2K and bringing the position to 66,057 shares worth $9.6M. The position accounts for 0.89% of the portfolio, ranked #10.

Lavaca Capital first reported a position in MRK in Q4 2018 and has held it in 32 quarters since. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Lavaca Capital held 66,057 shares of Merck worth $9.6M as of Q3 2026.
  • Lavaca Capital bought 284 Merck shares in Q3 2026, an estimated $39.2K.
  • Merck made up 0.89% of Lavaca Capital's portfolio in Q3 2026, its #10 holding.
  • Lavaca Capital first reported a position in Merck in Q4 2018 and has held it in 32 quarters since.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Lavaca Capital's 13F filing for Q3 2026, filed 16 Nov 2026.